Tag: generic drugs
-
26 Dec
-
4 Dec
Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand patents before launch, speeding up affordable drug access. This legal tool under the Hatch-Waxman Act saves billions annually but faces challenges from patent thickets and pay-for-delay deals. -
29 Nov
Are Generic Drugs Copies? The Truth Behind the Myth
Generic drugs are not copies - they're FDA-approved equivalents with the same active ingredients, strength, and effectiveness as brand-name drugs. Learn why they're safer, cheaper, and just as reliable. -
17 Nov
Quality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about generic drug quality as manufacturing shifts overseas. Studies show higher adverse events with Indian-made generics, while FDA inspections remain inconsistent. What patients and doctors need to know.
- Recent
- Popular
